Mitigate risk and ensure compliance for medical literature monitoring

The world's most comprehensive medical literature monitoring solution

The only end-to-end solution purpose-built specifically for Pharmacovigilance (PV) literature monitoring provides content, software and services

Ensure regulatory compliance and reduce operational costs while ensuring patient safety.

  • Identify relevant safety signals 5x faster
  • Reduce literature review volume by up to 50%
  • Balance precision recall never missing literature required for regulatory reporting
  • Ensure the organization is inspection ready with comprehensive supporting evidence such as audit trails, SOPs and training records.

Request more information

Comprehensive Content – Dialog consolidates and removes duplicates from biomedical literature including all databases used by EMA MLM service into a single trusted platform.

Automated Alerts Management – The Dialog Alerts Manager schedules and manages drug safety searches with easy bulk editing and a comprehensive audit trail.

Drug Safety Triager Software – Review medical literature for ICSR, Aggregate Reporting and potential safety signals, with administrative oversight, in a GxP validated solution that is inspection ready for regulators.

Literature Review and Search/Alert Services – Clarivate’s team of experts can manage the entire process from ensuring alerts are set up on your products to reviewing the safety literature for ICSRs and initial screening for Aggregate Reporting and Safety Signals.

Access authoritative literature monitoring content with precise search strategies and alerting built for PV

The Dialog platform delivers precision search across multiple databases such as MEDLINE, Embase, Biosis Previews, International Pharmaceutical Abstracts and Allied and Complementary Medicine ensuring all relevant drug safety results are identified.

With precision search, alerting system, deduplication and quality XML output, it is the industry standard for searching medical literature.

Accelerate literature screening through automated workflows, management oversight, and intuitive review interfaces

Drug Safety Triager is our GxP-validated and audit-ready pharmacovigilance (PV) literature review software solution, to monitor literature for Individual Case Safety Reporting, Aggregate Reports and Signal detection. It makes the drug safety literature monitoring process more efficient, cost-effective and compliant.

  • Up to 70% reduction of your Aggregate Report and Safety Signal review workload
  • 5x faster ability to identify reportable adverse events with assistance from our machine learning engine DialogML
  • 100% compliance with literature monitoring and reporting regulations

Our literature monitoring team helps our customers with critical, time-consuming and resource-intensive tasks within the drug safety monitoring workflow

One of the biggest challenges in pharmacovigilance literature monitoring is the volume of literature to be reviewed, with unexpected peaks. The right literature review team using the right pharmacovigilance software can assure timeline and quality compliance regardless of the challenges.

Our experienced Literature Review Services team has been performing literature screening, alerts set up and monitoring, and search services for some of the world’s biggest pharmaceutical companies, for many years, in a compliant, efficient and qualitative manner.

  • An experienced team
  • Trusted partner
  • A complete workflow

Our alerts services team helps our customers with setup and maintain PV search to ensure delivery of relevant safety literature

Trusted experts with decades of experience supporting searches for Aggregate Reporting along with alerts set up to review literature for ICSR, Aggregate Reporting and identification of potential Signals.

  • Ad-hoc Searching
  • Alerts Management
  • Alerts Review to ensure latest taxonomy changes apply
  • Best practices for ensuring the most relevant literature

Interested in learning more?

Speak to one of our experts to learn how to minimize literature monitoring risks and ensure regulatory compliance while maintaining patient safety standards.

Request more information